CEO Files Intent to Sell $2.79 Million in Shares
MLTX has more than doubled off its 52-week low of $5.95.
Summary
MoonLake Immunotherapeutics' CEO, Jorge Pedro Santos Radeck D Silva, has filed a Form 144 indicating intent to sell 150,000 shares, valued at approximately $2.79 million.
Key Events · Ownership and Investor Activity · MLTX
-
CEO Files Intent to Sell Shares
Jorge Pedro Santos Radeck D Silva, the CEO of MoonLake Immunotherapeutics, has filed a Form 144 indicating his intent to sell 150,000 Class A shares.
-
Proposed Sale Valued at $2.79 Million
The shares intended for sale are valued at approximately $2.79 million, representing a significant transaction for an executive.
-
Follows Recent Institutional Selling
This CEO filing comes shortly after BVF Partners, a significant institutional investor and affiliate of a director, reported substantial share sales earlier in April, indicating a broader pattern of insider and institutional distribution.
Analysis · MLTX · Life Sciences
The filing of a Form 144 by CEO Jorge Pedro Santos Radeck D Silva, indicating intent to sell a substantial amount of shares, is a negative signal. This executive selling follows recent significant share dispositions by a major institutional investor, BVF Partners, earlier this month. While the filing only indicates intent, it suggests a potential lack of conviction from a key insider, which could weigh on investor sentiment.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1052 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MLTX was trading at $19.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $5.95 to $62.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.